ClinicalTrials.gg
Not yet recruitingNCT07189533SENPRIUpdated Sep 24, 2025

SENior PRIorat: Participatory Research for the Improvement of Lifestyles, Quality of Life, Emotional Well-being, and Locomotor Abilities of Older Adults in the Priorat

An interventional study of Co-created intervention in Healthy Lifestyle, sponsored by University Rovira i Virgili. Not yet recruiting at 1 site in Spain. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-24.

Sponsored by University Rovira i Virgili · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

Spain is experiencing a demographic shift towards an ageing population. In 2022, 20.1% of Spaniards were 65 or older, a figure projected to reach 30.4% by 2050. The trend is especially marked in rural areas, where outmigration of younger generations has left a high concentration of older residents. In Catalonia's Priorat county, the share of people aged 65+ already exceeds 20%, reaching 30%, and even 40% in some villages.

The ageing process brings biological changes that reduce locomotor and cognitive abilities, limiting autonomy and quality of life. In rural areas, these challenges are compounded by social isolation and the lack of support networks, making older adults more vulnerable. Healthy lifestyle habits-such as balanced nutrition, regular exercise, avoiding tobacco and alcohol, and good sleep-can help delay dependence, lower the risk of chronic disease, and improve well-being. To promote these habits, social innovation must generate new services and approaches that address real needs, barriers, and motivations in adopting healthier lifestyles.

Our group's research shows that participatory science is an effective tool to promote healthy ageing in rural settings. A three-month intervention co-designed with older adults in villages of ≤2,000 inhabitants led to improvements in locomotor function, measured through sarcopenia parameters, and enhanced quality of life in areas such as vitality, mental health, and social functioning. A distinctive feature of this approach is shared decision-making between residents and policymakers, ensuring that solutions are adapted to local realities. This fosters greater adherence, empowerment, and long-term sustainability of co-created strategies.

This project is directly relevant to public policy through collaboration with the Consell Comarcal del Priorat, which represents 23 municipalities. Their recent report identified ageing as a major concern for both institutions and residents. The project's results can therefore guide health policies-decisions, plans, and actions-that address local needs while considering available resources and ensuring long-term sustainability.

By focusing on health promotion and disease prevention, the project ensures that policies are evidence-based and subject to evaluation. The partnership with the Consell Comarcal also aligns with Sustainable Development Goal 3 (Health and Well-being) of the 2030 WHO Agenda and supports the "Health in All Policies" approach, fostering integrated strategies across sectors.

The principal aim of the study is to evaluate the effectiveness of a participatory science intervention study in improving lifestyle habits (dietary habits, physical activity, substance use, and sleep quality), quality of life, emotional well-being, and locomotor capacities through the assessment of sarcopenia parameters (muscle strength, muscle mass, and physical function) in young-old adults (≥60 years) living in rural areas of the Priorat region (Catalonia, Spain).

Specific Objectives:

  1. To describe the health status of older people residing in the Priorat region by evaluating: lifestyle habits (diet, substance use, physical activity, and sleep), risk of malnutrition, functional capacity based on sarcopenia parameters, mental capacity (mental health and emotional well-being), and quality of life.
  2. To improve lifestyle habits (diet, physical activity, sedentary behaviour, sleep habits, and substance use-alcohol and smoking), emotional well-being and personal relationships to avoid unwanted loneliness, quality of life, and locomotor abilities based on sarcopenia parameters (muscle strength, muscle mass, and physical function).
  3. To reduce the risk of malnutrition.
  4. To compare the health status of two groups: those aged 60-74 (young-old adults) and those aged 75 and over (older people).
  5. To identify the needs, barriers, and motivations of older people through focus groups, including participants aged 60-74, those over 75, and stakeholders such as members of the public administration supporting the project.
  6. To compare the differences in needs, barriers, and motivations identified by the young-old adults (60-74 years) and the older people (≥75 years).
  7. To actively involve older participants in the co-creation of health promotion activities and an intervention designed for them and their peers.
  8. To implement an intervention based on proposals generated during the co-creation process to improve their lifestyle (dietary habits, physical activity, substance use, well-being, and sleep behaviours), quality of life, and locomotor abilities.
  9. To analyse environmental barriers, using the "Age-Friendly Cities and Communities Questionnaire (AFCCQ)", in the villages of the Priorat region that may influence the ability to maintain a healthy lifestyle and quality of life for people aged 60-74 and those aged 75 and over.
Read the detailed description

The study will last for 24 months and will be structured into various tasks:

Tasks 1 and 2. Recruitment of villages and participants

  1. Villages: In collaboration with the Consell Comarcal del Priorat, the strategy for contacting the villages will be decided, whether through local councils, community centres, elderly associations, etc. Dissemination may be carried out through posters, social media, letters to residents, electronic bulletins (e-bando), etc.

    The villages in the Priorat region interested in participating will be randomly assigned into two groups: control group (at least 5 villages with 8 participants each) and intervention group (at least 5 villages with 8 participants each).

  2. Participants:

    • Older adults (both young-old and elderly) who choose to take part in the project will sign an informed consent form.
    • Stakeholders from the quadruple helix model: companies, government officials, academic institutions, and the community members who may influence the lifestyles of older adults (both young-old adults and elderly) in the rural Priorat region will be contacted by phone or email and informed about the project. Stakeholders will also sign an informed consent form.

Task 3. Characterisation of participants Questionnaires about lifestyles and anthropometric measurements will be completed in small sessions, individually, in person, and on paper. Also, focus groups will be done to gather insights into participants' perceptions of ageing, their needs, barriers, and motivations to improve and maintain healthy lifestyles. Three separate focus groups will be conducted with: young-old adults (60-74 years), elderly adults (≥75 years), and stakeholders, each consisting of 6-8 participants.

Focus groups are structured, moderated group discussions where participants are encouraged to freely express their opinions in response to specific questions. Each session will last approximately 75 minutes and be led by an external moderator.

Baseline data (questionnaires and focus group data) will be analyzed to prepare the co-creation process, ensuring that it is adapted to the real needs and characteristics of the population.

Task 4. Co-creation of solutions Based on the information gathered during the initial characterisation (baseline assessments and focus groups), solutions will be developed through a co-creation process involving older participants (young-old and elderly) from the intervention groups and the stakeholders.

The co-creation session (lasting 4 hours) will follow the PRODUCES framework: a) Problem: Unhealthy lifestyles among people aged ≥ 60 years old, b) Objective: To design solutions to improve lifestyles of people aged ≥ 60 years old, c) Design: Participatory research to increase individual empowerment, d) Users: People aged ≥ 60 years old, e) Co-creators: Stakeholders and older adults, f) Evaluation: Through comparison of intervention and control group, g) Scalability: Model generalisable to other similar areas with elderly populations.

The co-creation process is structured as follows: a) Co-ideation: Word Café dynamics, b) Co-design of the most voted ideas, c) Collaborative prototyping and testing. After sharing ideas, activities, events, dissemination materials, and any other elements deemed necessary to address identified barriers and needs related to lifestyle will be designed.

Proposed activities that provide solutions and fall within the project's budget (agreed upon with the Consell Comarcal del Priorat to ensure sustainability) will be presented and discussed among participants. Finally, participants will take part in prioritizing proposals and defining the final solutions to be implemented."

Task 5. Implementation of the intervention in the intervention villages The co-created intervention for older adults (young-old and elderly) in Priorat villages will be implemented in IG village over 6 months.

Once the intervention has been implemented in intervention villages, the same will be offered to control villages, but without further evaluation, to avoid bias and ensure fair access to potential benefits.

Task 6. Participant characterization (younger-old and older-old) - final assessment: Both participants who received the intervention and those in the control group will be evaluated by questionnaires about lifestyles and anthropometric measurements, to compare any differences between those who underwent the intervention and those who did not.

02

Conditions studied

  • Healthy Lifestyle

Keywords

  • Participatory research
  • healthy lifestyle
  • quality of life
  • older adults
  • rural environment
03

In context

Lead sponsor

University Rovira i Virgili is the lead sponsor of 53 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 60 years or older
  • Signed
  • Living independently
  • Capacity to follow and complete the study
  • Resident in one of the villages of the Priorat region

Exclusion criteria

Exclusion Criteria:

Failure to meet any of the inclusion criteria will be considered grounds for exclusion.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Intervention

    Receive the co-created intervention

    Behavioral: Co-created intervention

  • No intervention
    Control

    still with their habitual lifestyle

Interventions

  • BehavioralCo-created intervention

    Intervention generated by a participatory research process (co-creation) in the elderly population living in rural areas to co-create solutions to improve their lifestyles, quality of life and health.

06

What researchers measure

Primary outcomes

  1. Nutritional intake

    The Food Frequency Consumption Questionnaire (FFCQ) (Rodríguez IT, et al. Nutr Hosp. 2008) to assess the nutritional intake of elderly participants.

    Time frame: Baseline and follow-up (6 months later)

  2. Physical activity and sedentary behaviour

    International physical activity questionnaire for elderly: IPAQ for elderly IPAQ-E, Spanish version (Rubio-Castañeda et al., 2017). Higher scores mean a better outcome.

    Time frame: Baseline and follow-up (6 months later)

  3. Sleep quality

    Pittsburgh questionnaire (Buysse et al., 1989). The maximum score is 21 points. More than 5 points are considered bad outcomes and sleep problems, and less than 5 points are considered better outcomes and no sleep problems.

    Time frame: Baseline and follow-up (6 months later)

  4. Depressive symptoms

    Geriatric Depression Scale Questionnaire (Yesavage et al., 1983). The maximum punctuation is 15. The score is 0-4, no depression; 5-8, mild depression; 9-11, moderate depression; and 12-15, severe depression.

    Time frame: Baseline and follow-up (6 months later)

  5. Quality of life behaviours

    Quality of life assessed by the SF-36 Health survey questionnaire (Ware \& Sherbourne, 1992) and the EuroQol-5D questionnaire (Herdman M et al., 2001). Higher scores mean a better outcome.

    Time frame: Baseline and follow-up (6 months later)

  6. Muscle strength

    The muscle strength assessed by handgrip dynamometry (Jamar dynamometer; Sammons Preston Rolyan, Bolingbrook, IL).

    Time frame: Baseline and follow-up (6 months later)

  7. Muscle mass

    Muscle mass (appendicular skeletal muscle mass (kg)) assessed by Bioimpedance TANITA (MC-780MA; Tanita Corp., Tokyo, Japan).

    Time frame: Baseline and follow-up (6 months later)

  8. Physical performance

    Gait speed (m/s) assessed by the length of the walking course divided by the time (Ladang et al., 2023).

    Time frame: Baseline and follow-up (6 months later)

  9. Nutritional status

    Hemoglobin (g/dl) in blood samples assessed by HemoCue® Hb 801 (HemoCue AB, Ängelholm, Suecia, 2020).

    Time frame: Baseline and follow-up (6 months later)

Secondary outcomes

  1. Nutritional status

    Mini Nutritional Assessment Short-Form (MNA-SF). The maximum punctuation is 14 points. The score is 0-7 points (malnutrition), 8-11 points (risk of malnutrition), and 12-14 points (normal nutritional status).

    Time frame: Baseline and follow-up (6 months later)

  2. Anthropometric measures

    Height (cm) measured by wall-mounted stadiometer (Tanita Leicester Portable; Tanita Corp., Barcelona, Spain)

    Time frame: Baseline and follow-up (6 months later)

  3. Anthropometric measures

    Weight (kg) measured by calibrated scale (TANITA MC-780MA; Tanita Corp., Tokyo, Japan).

    Time frame: Baseline and follow-up (6 months later)

  4. Anthropometric measures

    BMI (kg/m2) is calculated by dividing weight (kg) by height (m2).

    Time frame: Baseline and follow-up (6 months later)

  5. Anthropometric measures

    WC: waist circumference (cm) measured by steel measuring tape (at the umbilicus).

    Time frame: Baseline and follow-up (6 months later)

  6. Anthropometric measures

    Calf circumference(cm) measured by steel measuring tape.

    Time frame: Baseline and follow-up (6 months later)

  7. Vascular parameters

    Systolic and diastolic blood pressure (SBP and DBP) (mm Hg) and pulse pressure (PP) (mm Hg) assessed by an automatic sphygmomanometer (OMRON HEM-907; Peroxfarma, Barcelona, Spain).

    Time frame: Baseline and follow-up (6 months later)

  8. Muscle mass

    Muscle mass thickness of quadriceps and forearm assessed by ultrasound (VINNO 5 (Vinno (Suzhou) Co., Ltd., China)

    Time frame: Baseline and follow-up (6 months later)

  9. Abdominal fat

    Abdominal fat assessed by ultrasound (VINNO 5 (Vinno (Suzhou) Co., Ltd., China)

    Time frame: Baseline and follow-up (6 months later)

  10. Healthy and friendly communities

    Age-Friendly Cities and Communities Questionnaire (AFCCQ) with eight domains (housing, social participation, respect and social inclusion, civic participation and employment, communication and information, community support and health services, outdoor spaces and buildings, transportation, financial situation). All domains are answered on a 5-point scale, ranging from totally disagree to totally agree. Scores: -2 = totally disagree; -1 = disagree; 0 = neutral; 1 = agree; 2 = totally agree. Higher scores in each domain mean a better outcome.

    Time frame: Baseline and follow-up (6 months later)

  11. Socio-familiar situation

    Socio-familiar situation assessed through the validated questionnaire Socio-Familial Assessment Scale (TSO) (Giménez Bertomeu VM, et al. 2020), based on different indicators (family structure and function, social contacts, required support, and receipt of resources for activities of daily living, economic income, and housing).

    Time frame: Baseline and follow-up (6 months later)

  12. Other health determinants

    Other health determinants that participants considered important to address, selected during the focus groups.

    Time frame: Baseline and follow-up (6 months later)

  13. Lipid profile

    Total cholesterol (mmol/L) in blood samples assessed by Cobas Mira Plus autoanalyzer (Roche Diagnostics Systems, Madrid, Spain).

    Time frame: Baseline and follow-up (6 months later)

  14. Lipid profile

    HDLc (mmol/L) in blood samples assessed by Cobas Mira Plus autoanalyzer (Roche Diagnostics Systems, Madrid, Spain).

    Time frame: Baseline and follow-up (6 months later)

  15. Lipid profile

    LDLc (mmol/L) in blood samples assessed by Cobas Mira Plus autoanalyzer (Roche Diagnostics Systems, Madrid, Spain).

    Time frame: Baseline and follow-up (6 months later)

  16. Lipid profile

    Total TG (mmol/L) in blood samples assessed by Cobas Mira Plus autoanalyzer (Roche Diagnostics Systems, Madrid, Spain).

    Time frame: Baseline and follow-up (6 months later)

  17. Glucose homeostasis

    Fasting blood glucose (mmol/L)in blood samples assessed by OneTouch Select Plus Flex®.

    Time frame: Baseline and follow-up (6 months later)

  18. Glucose homeostasis

    HGBA1c (%) in blood samples assessed by Cobas Mira Plus autoanalyzer (Roche Diagnostics Systems, Madrid, Spain).

    Time frame: Baseline and follow-up (6 months later)

  19. Inflamation markers

    High-sensitivity C-reactive protein (mg/dL) in blood samples assessed by Cobas Mira Plus autoanalyzer (Roche Diagnostics Systems, Madrid, Spain).

    Time frame: Baseline and follow-up (6 months later)

  20. Urine metabolites

    Metabolomic characterization: targeted metabolomics for the detection of over 1,000 metabolites. Targeted metabolomic analysis is performed using a liquid chromatography-tandem mass spectrometry (LC-MS/MS) platform, employing multiple reaction monitoring (MRM) in both positive and negative ionization modes. The protocol includes a prior chemical derivatization step, followed by separation via reversed-phase liquid chromatography (RP-LC) and/or direct flow injection to the mass spectrometer (DFI-MS) for the analysis of the target metabolites. Quantification is carried out using internal isotopic standards and multipoint calibration curves, allowing for absolute concentration determination. (Zheng J, et al. Anal Chem. 2020; 92(15):10664-70/ Zhang L, et al. Metabolites. 2024;14(11):622)

    Time frame: Baseline and follow-up (6 months later)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2025; primary completion for Dec 2026, 14 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 16, 2025
First posted
Sep 24, 2025
StartEst.
Oct 6, 2025
Primary completionEst.
Dec 30, 2026
CompletionEst.
Apr 30, 2027
Last update
Sep 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07189533
Lead sponsor
University Rovira i Virgili
Collaborators
Consell Comarcal del Priorat, Fundación para la Ciencia y la Tecnología
Responsible party
Elisabet Llauradó (Doctor, Lecturer, University Rovira i Virgili) — Principal investigator
First posted
Sep 24, 2025
Start date
Oct 6, 2025 (estimated)
Primary completion
Dec 30, 2026 (estimated)
Completion
Apr 30, 2027 (estimated)
Last update
Sep 24, 2025

Study contacts

Elisabet Llauradó, PhD
Contact
elisabet.llaurado@urv.cat
+34977759375 ext. 9375

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion